Roughly two weeks apart, on July 21, 2022 and August 5, 2022, respectively, Amazon made headlines for agreeing to acquire One Medical, “a human-centered and technology-powered primary care organization,” for approximately $3.9 billion and iRobot, a global consumer robot company, known for its creation of the Roomba vacuum, for approximately $1.7 billion. These proposed acquisitions have drawn the scrutiny of the Federal Trade Commission (FTC), which following President Biden’s 2021 Executive Order on antitrust and competition, has taken a more aggressive stance toward acquisitions by large technology companies in an effort to, in FTC Chair Lina Khan’s words, “prevent incumbents from unlawfully capturing control over emerging markets.”

Beyond antitrust issues, Amazon’s recent acquisition decisions bring the discussion of the collection of consumer information and its secondary uses, specifically location and health data (which we have previously written about), to the forefront, yet again.

Read the full post on our Privacy Law Blog.

Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of Ryan P. Blaney Ryan P. Blaney

Ryan Blaney represents health care, life science, and technology clients in a range of regulatory, enforcement, internal investigative and transactional matters, with particular expertise in privacy law, life sciences and digital health. He also has expertise in regulatory compliance, counseling clients on a…

Ryan Blaney represents health care, life science, and technology clients in a range of regulatory, enforcement, internal investigative and transactional matters, with particular expertise in privacy law, life sciences and digital health. He also has expertise in regulatory compliance, counseling clients on a range of matters, including health care fraud and abuse, third party reimbursement, data breach issues, data privacy and security, and FDA regulatory matters. He has substantial experience in pharmaceutical lifecycle management and competition issues, including the Hatch- Waxman Act and Biosimilars Price Competition and Innovations Act.

Ryan serves information technology companies, public and private health care companies, hospitals and physician organizations, manufacturers, medical device companies, and health plans. He guides venture capital groups, private equity funds, investment banks, and other investors on health care regulatory issues in connection with financing, mergers and acquisitions, and restructuring.

Ryan’s work is greatly informed by his experience as a teacher. Prior to attending law school, Ryan earned a master’s degree in education and taught at an under-resourced Catholic middle school. He is known for his ability to communicate clearly and to coordinate large teams working on complex matters. Outside of his health law practice, Ryan has been repeatedly recognized for his public service and pro bono work. He has successfully handled numerous education-related cases, helped establish three nonprofit organizations and defended qualified recipients of disability benefits.

Photo of Danielle Brooks Danielle Brooks

Dani Brooks is an associate in the Corporate Department and a member of the Technology, Media & Telecommunications Group.

Dani earned her J.D. from the Georgetown University Law Center in 2021. While at Georgetown, Dani interned with the Legal Aid Society in its…

Dani Brooks is an associate in the Corporate Department and a member of the Technology, Media & Telecommunications Group.

Dani earned her J.D. from the Georgetown University Law Center in 2021. While at Georgetown, Dani interned with the Legal Aid Society in its Queens Housing Law Practice; worked as a Honor Student Volunteer for the U.S. Securities and Exchange Commission in its Enforcement Division, specifically the Office of the Whistleblower; and joined the Policy Clinic at the Harrison Institute for Public Law as a member of its Health and Food Team.

Prior to law school, Dani graduated summa cum laude from Vanderbilt University with a B.A. in Medicine, Health, and Society (MHS) and minors in both Corporate Strategy and Psychology. Dani received the Top Scholar Award for earning the highest GPA among all Class of 2018 MHS graduates.